1 |
20 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
2 |
20 mg bid of pf-02545920 |
- |
- |
- |
- |
008 [1] 8 💬 |
3 |
20 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
4 |
20 mg ga |
- |
- |
- |
- |
013 [1] 13 💬 |
5 |
20 mg mitoq |
- |
- |
- |
- |
013 [1] 13 💬 |
6 |
20 mg sildenafil citrate by mouth |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
7 |
Acomplia 20 mg film-coated tablets |
- |
- |
- |
- |
193 [1] 193 💬 |
8 |
Adcirca 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
9 |
Apremilast 20 mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 [1] 46 💬 |
10 |
Apremilast tablet 20 mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
271 [1] 271 💬 |
11 |
Arava 20 mg filmdrasjerte tabletter |
- |
- |
- |
- |
046 [1] 46 💬 |
12 |
Arava 20 mg tablets (aventis pharmaceutical, inc.) |
- |
- |
- |
- |
046 [1] 46 💬 |
13 |
Arc1905 20 mg/ml |
- |
- |
- |
- |
301 [1] 301 💬 |
14 |
Atorvastatin tablet 20 mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [1] 46 💬 |
15 |
Azd9567 20 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
16 |
Baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
17 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
18 |
Bardoxolone methyl 20 mg |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
19 |
Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour udca therapy |
Bezafibrate |
[2] D00734 D00734, D01366 D01366 💬 |
NR1H4 [2] NR1H4, PPARA 💬 |
Adipocytokine signaling pathway [9] Adipocytokine signaling pathway, Bile secretion, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
094 [1] 94 💬 |
20 |
Bf 2.649 20 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
21 |
Bibr 796 bs, 20 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
22 |
Btt1023 iv infusion 20 mg/ml, 5 ml drug product |
- |
- |
- |
- |
094 [1] 94 💬 |
23 |
Carbidopa 20 mg |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
24 |
Chronocort® 20 mg |
- |
- |
- |
- |
081 [1] 81 💬 |
25 |
Cialis - 20 mg 2 compresse rivestite con film in blister uso orale |
- |
- |
- |
- |
075 [1] 75 💬 |
26 |
Cialis 20 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
27 |
Cialis 20 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
28 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 [1] 13 💬 |
29 |
Copaxone 20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
30 |
Copaxone 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
31 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
32 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
33 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
34 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 [1] 13 💬 |
35 |
Cortancyl 20 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
36 |
Cortancyl ® 20 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
37 |
Decortin 20 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
38 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
39 |
Doptelet 20 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
40 |
Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel |
- |
- |
- |
- |
006 [1] 6 💬 |
41 |
Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
42 |
Encapsulated baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
43 |
Esomeprazole 20 mg |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
046 [1] 46 💬 |
44 |
Famotidine 20 mg |
Famotidine |
[1] D00318 D00318 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
086 [1] 86 💬 |
45 |
Ga 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
46 |
Glatiramer acetate 20 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
47 |
Glatiramer acetate 20 mg, with mitoxantrone |
Acetate |
[3] D02166 D02166, D04318 D04318, D08224 D08224 💬 |
HLA-A [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 |
Allograft rejection [33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
48 |
Glatiramer acetate 20 mg/0.5 ml |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
49 |
Gwp42003-p 20 mg/kg/day dose |
- |
- |
- |
- |
140 [2] 140, 144 💬 |
50 |
Humira 20 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
51 |
Infliximab 20 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
52 |
Ipx056 20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
53 |
Ipx056-20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
54 |
Isosorbide dinitrate 20 mg |
Isosorbide |
[2] D00347 D00347, D00516 D00516 💬 |
- |
- |
113 [1] 113 💬 |
55 |
Istradefylline 20 mg |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
56 |
Istradefylline 20 mg or 40 mg |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
57 |
Lci699, 20 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
58 |
Leflunomide 20 mg tablets (geneva pharmaceutical) |
Leflunomide |
[1] D00749 D00749 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 [1] 46 💬 |
59 |
Leflunomide 20 mg+prednisone 0.5mg/kg/d |
Leflunomide |
[2] D00473 D00473, D00749 D00749 💬 |
DHODH [2] DHODH, NR3C1 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism |
066 [1] 66 💬 |
60 |
Lenabasum 20 mg |
- |
- |
- |
- |
050 [3] 50, 51, 299 💬 |
61 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
62 |
Lojuxta 20 mg hard capsules |
- |
- |
- |
- |
079 [1] 79 💬 |
63 |
Losec capsules 20 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
64 |
Ly3337641 20 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
65 |
Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d |
Melarsoprol |
[2] D00832 D00832, D00833 D00833 💬 |
- |
- |
065 [1] 65 💬 |
66 |
Methylphenidate modified release 20 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
67 |
Mozobil - 20 mg/ml - soluzione iniettabile - uso sottocutaneo - f |
- |
- |
- |
- |
019 [1] 19 💬 |
68 |
Mozobil - 20 mg/ml - soluzione iniettabile - uso sottocutaneo - flaconcino (vetro) - 24 mg/1.2 ml 1 flaconcino |
- |
- |
- |
- |
065 [1] 65 💬 |
69 |
Mysildecard 20 mg |
- |
- |
- |
- |
210 [1] 210 💬 |
70 |
Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d |
Eflornithine |
[2] D00833 D00833, D07883 D07883 💬 |
ODC1 [1] ODC1 💬 |
Arginine and proline metabolism [3] Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways |
065 [1] 65 💬 |
71 |
Omaveloxolone capsules, 20 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
72 |
Omeprazole 20 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [2] 96, 97 💬 |
73 |
Oxn 20 mg / 10 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
74 |
Oxycodone/naloxone prolonged release tablets 20 mg /10 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
75 |
Pantoprazolo 20 mg gastro-resistant tablets |
- |
- |
- |
- |
065 [1] 65 💬 |
76 |
Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
77 |
Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
78 |
Pf-06650833 20 mg |
PF-06650833 |
- |
- |
- |
046 [1] 46 💬 |
79 |
Plenadren 20 mg modified-release tablets |
- |
- |
- |
- |
078 [1] 78 💬 |
80 |
Plovamer acetate 20 mg |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
81 |
Pn 200 tablets (500 mg naproxen and 20 mg omeprazole) |
Naproxen |
[5] D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [2] 46, 271 💬 |
82 |
Ponesimod 20 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
83 |
Prednisolone 20 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
84 |
Prednison acis® 20 mg |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
85 |
Revatio 20 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
86 |
Revatio 20 mg film coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
87 |
Revatio 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
88 |
Revatio 20 mg filmtabletten |
- |
- |
- |
- |
086 [1] 86 💬 |
89 |
Revatio 20 mg, comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
90 |
Revatio ® 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
91 |
Rivaroxaban 20 mg |
Rivaroxaban |
[1] D07086 D07086 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
091 [1] 91 💬 |
92 |
Roactemra 20 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
93 |
Roactemra 20 mg/ml concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
94 |
Roactemra 20 mg/ml concentrate for solution for infusion. |
- |
- |
- |
- |
046 [1] 46 💬 |
95 |
Roactemra 20 mg/ml, concentrado para solución para perfusión |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
96 |
Sandostatin lar 20 mg |
- |
- |
- |
- |
227 [1] 227 💬 |
97 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 [1] 67 💬 |
98 |
Sildenafil (revatio) 20 mg tid |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
99 |
Sildenafil 20 mg tablets |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
278 [1] 278 💬 |
100 |
Simvastatin 20 mg |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [1] 46 💬 |
101 |
Som230 lar, 20 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
102 |
Tadalafil 20 mg |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 [1] 113 💬 |
103 |
Tadalafil 20 mg film-coated tablets |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
104 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
105 |
Targinact 20 mg/10 mg prolonged-release tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
106 |
Tpi-287 20 mg/m2 |
- |
- |
- |
- |
005 [2] 5 , 7 💬 |
107 |
Zx008 - 20 mg/day maximum dose |
- |
- |
- |
- |
140 [1] 140 💬 |